Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
590,231,680
-
Total 13F shares
-
501,621,113
-
Share change
-
+4,233,269
-
Total reported value
-
$39,209,886,931
-
Put/Call ratio
-
52%
-
Price per share
-
$78.21
-
Number of holders
-
1,244
-
Value change
-
+$342,426,550
-
Number of buys
-
561
-
Number of sells
-
550
Institutional Holders of Edwards Lifesciences Corp - Common Stock (EW) as of Q2 2025
As of 30 Jun 2025,
Edwards Lifesciences Corp - Common Stock (EW) was held by
1,244 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
501,621,113 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock, Inc., JPMORGAN CHASE & CO, STATE STREET CORP, WELLINGTON MANAGEMENT GROUP LLP, Bank of New York Mellon Corp, CITADEL ADVISORS LLC, GEODE CAPITAL MANAGEMENT, LLC, JENNISON ASSOCIATES LLC, and DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main.
This page lists
1,245
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.